Turk J Hematol. 2021; 38(1): 87-89 | DOI: 10.4274/tjh.galenos.2020.2020.0521

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia

Wanlu Ma¹, JiaWei Zhao², Lu Zhang^3
1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China
²Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
³Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Keywords: Waldenstrom macroglobulinemia, Rituximabinduced thrombocytopenia, Ixazomib

---

Waldenström Makroglobulinemisinde Rituksimab İçermeyen Yeni Umut Verici Oral Iksazomib Tedavisi

Wanlu Ma¹, JiaWei Zhao², Lu Zhang^3
1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China
²Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
³Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Anahtar Kelimeler: Waldenström makroglobülinemisi, Rituksimab ile indüklenen trombositopeni, Iksazomib

---

CITE